Search results for "d-a"

showing 10 items of 426 documents

Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal bac…

2013

Background The organic nitrate pentaerithrityl tetranitrate (PETN) has been shown to have ancillary properties that prevent the development of tolerance and endothelial dysfunction. This randomized, double-blind, placebo-controlled, multicentre study (‘CLEOPATRA’ study) was designed to investigate the anti-ischaemic efficacy of PETN 80 mg b.i.d. (morning and mid-day) over placebo in patients with chronic stable angina pectoris. Methods and results A total of 655 patients were evaluated in the intention-to-treat population, randomized to PETN (80 mg b.i.d., n = 328) or placebo ( n = 327) and completed the study. Patients underwent treadmill exercise tests at randomization, after 6 and 12 wee…

Malemedicine.medical_specialtyRandomizationmedicine.drug_classVasodilator AgentsPopulationAdrenergic beta-AntagonistsPlacebo-controlled studyPlaceboAdrenergic beta-AntagonistsMedication AdherenceDouble-Blind MethodmedicineClinical endpointHumansPentaerythritol TetranitrateAngina StableEndothelial dysfunctioneducationBeta blockereducation.field_of_studyExercise Tolerancebusiness.industryMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeAnesthesiaDelayed-Action PreparationsChronic DiseaseExercise TestFemaleCardiology and Cardiovascular MedicinebusinessEuropean heart journal
researchProduct

Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: Implicatio…

2009

Tumor necrosis factor (TNF)-alpha is a proinflammatory cytokine acting on two distinct receptor subtypes, namely p55 and p75 receptors. TNF-alpha p55 and p75 receptor knockout mice were previously shown to display a decreased or enhanced susceptibility to seizures, respectively, suggesting intrinsic modifications in neuronal excitability. We investigated whether alterations in glutamate system function occur in these naive knockout mice with perturbed cytokine signaling that could explain their different propensity to develop seizures. Using Western blot analysis of hippocampal homogenates, we found that p55(-/-) mice have decreased levels of membrane GluR3 and NR1 glutamate receptor subuni…

Malemedicine.medical_specialtyReceptors Kainic acidMicrodialysisAction PotentialsGlutamic AcidKainate receptorAMPA receptorIn Vitro TechniquesBiologyHippocampusReceptors N-Methyl-D-Aspartateelectrophysiology microiontophoresisSettore BIO/09 - FisiologiaMicechemistry.chemical_compoundGlutamatergicReceptors Kainic AcidSeizuresInternal medicinemedicineAnimalsReceptors Tumor Necrosis Factor Type IIReceptors AMPAMice KnockoutNeuronsInflammationTumor Necrosis Factor-alphaGeneral NeuroscienceGlutamate receptorProtein SubunitsEndocrinologymedicine.anatomical_structureReceptors Glutamatenervous systemchemistryReceptors Tumor Necrosis Factor Type IMetabotropic glutamate receptorAstrocytesCytokinesNMDA receptorNBQXDisease SusceptibilityAstrocyte
researchProduct

Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes.

2005

The lipid triad is the association of small, dense (sd) low-density lipoprotein (LDL), low high-density lipoprotein (HDL), and hypertriglyceridemia, all of which play a role in coronary artery disease in patients with type 2 diabetes. Although statins have demonstrated clear positive effects on cardiovascular morbidity/mortality in patients with diabetes and on single components of the lipid triad, it remains controversial whether they affect all components of the triad in these patients. Therefore, we performed a single-center, parallel-group, prospective, randomized, open-label, blinded-endpoint (PROBE)-type comparison of fluvastatin extended-release (XL) 80 mg (n=48) and simvastatin 20 m…

Malemedicine.medical_specialtySimvastatinIndolesHDLApolipoprotein BSmall dense LDLType 2 diabetesTriglycerideLDLFatty Acids MonounsaturatedFluvastatin XLInternal medicineDiabetes mellitusType 2 diabetes mellitusmedicineHumansPharmacology (medical)Prospective StudiesFluvastatinAgedHypertriglyceridemiabiologybusiness.industryAnticholesteremic AgentsApoA-IHypertriglyceridemianutritional and metabolic diseasesType 2 Diabetes MellitusGeneral MedicineMiddle Agedmedicine.diseaseLipoproteins LDLEndocrinologyDiabetes Mellitus Type 2SimvastatinDelayed-Action Preparationsbiology.proteinlipids (amino acids peptides and proteins)FemaleApoBbusinessLipoproteins HDLFluvastatinmedicine.drugLipoproteinAdvances in therapy
researchProduct

Statin Use and Knee Osteoarthritis Outcomes: A Longitudinal Cohort Study

2018

Objective: Statins have several pleiotropic effects, but the literature regarding the possible relationship between use of statins and outcomes in knee osteoarthritis (OA) is limited. The aim of this study was to investigate whether statin use is associated with a lower risk of radiographic OA (ROA), radiographic symptomatic knee OA, and pain in North American individuals. Methods: A total of 4,448 community-dwelling adults from the Osteoarthritis Initiative were followed for 4 years. Statin use (including the time from baseline and the type of statin) was defined through self-report information and confirmed by a trained interviewer. Knee OA outcomes included incident ROA, symptomatic knee…

Malemedicine.medical_specialtyStatinmedicine.drug_classAtorvastatinPROGRESSIONOsteoarthritisLower riskTHERAPYArticleCohort Studies03 medical and health sciences0302 clinical medicineRheumatologyInternal medicinemedicineHumansEPIDEMIOLOGYRosuvastatinLongitudinal StudiesSCALEAgedddc:616030203 arthritis & rheumatologyRISKbusiness.industryIncidencenutritional and metabolic diseasesMiddle AgedOsteoarthritis Kneemedicine.diseaseDEPRESSIONRHEUMATOID-ARTHRITISKnee painRelative riskFemalemedicine.symptomHydroxymethylglutaryl-CoA Reductase Inhibitorsbusinessmedicine.drugCohort study
researchProduct

Transient oligemia is associated with long-term changes in binding densities of cortical inhibitory GABAA receptors in the rat brain

2009

Recently, we could demonstrate in rats that a short transient oligemic period of only 20-minute duration, induced by systemic hypotension, resulted in a transient decline of spatial memory capacities without any histological damage over a subsequent period of 6 months. In our present study, we checked for more subtle alterations within the highly vulnerable hippocampal CA1 subfield using quantification of neuronal cell density and semi-quantitative analysis of the ischemia-sensitive protein MAP2. Since hippocampal excitatory and inhibitory neurotransmitter receptors are crucially involved in spatial memory processes, quantitative in vitro receptor autoradiography was performed using [(3)H]M…

Malemedicine.medical_specialtyTime FactorsDown-RegulationAMPA receptorHippocampal formationTritiumInhibitory postsynaptic potentialBinding CompetitiveHippocampusReceptors N-Methyl-D-AspartateTimeRadioligand Assaychemistry.chemical_compoundParietal LobeInternal medicinemedicineAnimalsReceptors AMPARats WistarReceptorGABA AgonistsMolecular Biologygamma-Aminobutyric AcidCerebral CortexMemory DisordersMuscimolChemistryGABAA receptorGeneral NeuroscienceReceptors GABA-ARatsDisease Models AnimalEndocrinologynervous systemMuscimolHypoxia-Ischemia BrainExcitatory postsynaptic potentialNMDA receptorNeurology (clinical)Microtubule-Associated ProteinsDevelopmental BiologyBrain Research
researchProduct

Pravastatin treatment causes a shift in the balance of hippocampal neurotransmitter binding densities towards inhibition

2009

Since pravastatin, a HMG-CoA reductase inhibitor, has recently been shown to reduce infarct volumes and glutamate release in a rat model of ischemic stroke, the aim of the present study was to investigate whether this neuroprotective effect may be due to a modulation of excitatory and inhibitory neurotransmitter receptors. Therefore, Wistar rats were treated six times in 4 days with pravastatin or saline and allowed to survive for 6 hours or 5 days (n=10 per time point and group), respectively. Using quantitative receptor autoradiography, ligand binding densities of [(3)H]MK-801, [(3)H]AMPA, and [(3)H]muscimol for labeling of NMDA, AMPA, and GABA(A) receptors were analyzed in sensorimotor c…

Malemedicine.medical_specialtyTime FactorsKainate receptorAMPA receptorBiologyPharmacologyHippocampusReceptors N-Methyl-D-AspartateNeurotransmitter bindingRandom Allocationchemistry.chemical_compoundInternal medicinemedicineAnimalsReceptors AMPARats WistarLong-term depressionMolecular Biology5-HT receptorPravastatinCerebral CortexNeurotransmitter AgentsGABAA receptorGeneral NeuroscienceGlutamate receptorReceptors GABA-ACorpus StriatumRatsNeuroprotective AgentsEndocrinologynervous systemMuscimolchemistryNeurology (clinical)Developmental BiologyBrain Research
researchProduct

‘Not at all what I had expected’: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study

2021

Background: Extended-release naltrexone (XR-NTX), an opioid antagonist, has demonstrated equal treatment outcomes, in terms of safety, opioid use, and retention, to the recommended OMT medication buprenorphine. However, premature discontinuation of XR-NTX treatment is still common and poorly understood. Research on patient experiences of XR-NTX treatment is limited. We sought to explore participants' experiences with discontinuation of treatment with XR-NTX, particularly motivation for XR-NTX, experiences of initiation and treatment, and rationale for leaving treatment. Methods: We conducted qualitative, semi-structured interviews with participants from a clinical trial of XR-NTX. The study…

Malemedicine.medical_specialtymedicine.drug_classNarcotic Antagonistsmedia_common.quotation_subjectMedicine (miscellaneous)Injections IntramuscularNaltrexonemedicineHumansVDP::Medisinske Fag: 700PsychiatryQualitative Researchmedia_commonbusiness.industryClinical Studies as TopicAbstinenceOpioid-Related DisordersNaltrexoneBuprenorphineDiscontinuationAnalgesics OpioidClinical trialPsychiatry and Mental healthClinical PsychologyVDP::Medisinske Fag: 700::Helsefag: 800Delayed-Action PreparationsFemalePshychiatric Mental HealthThematic analysisbusinesshuman activitiesOpioid antagonistQualitative researchmedicine.drugBuprenorphine
researchProduct

Magnetresonanztomographie (MRT) der Leber und des Gehirns bei hämatologisch-onkologischen Patienten mit Fieber unbekannter Ursache

1998

PURPOSE To examine the advantage of liver and brain MRI in clinically anomalous haematological patients with fever of unknown origin. MATERIAL AND METHODS Twenty liver MRI (T2-TSE, T2-HASTE, T1-FLASH +/- Gd dynamic) and 16 brain MRI (T2-TSE, FLAIR, T1-TSE +/- Gd) were performed searching for a focus of fever with a suspected organ system. Comparison with clinical follow-up. RESULTS A focus was detected in 11/20 liver MRI. Candidiasis (n = 3), mycobacteriosis (n = 2), relapse of haematological disease (n = 3), graft versus host disease (n = 1), non-clarified (n02). The remaining 9 cases with normal MRI were not suspicious of infectious hepatic disease during follow-up. In brain MRI, 3/16 sho…

MastoiditisPathologymedicine.medical_specialtybusiness.industryFluid-attenuated inversion recoverymedicine.diseaseAspergillosisToxoplasmosisCentral nervous system diseaseGraft-versus-host diseasemedicineRadiology Nuclear Medicine and imagingFever of unknown originbusinessMycosisRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Poly-l-Lactic Acid Nanofiber-Polyamidoamine Hydrogel Composites: Preparation, Properties, and Preliminary Evaluation as Scaffolds for Human Pluripote…

2016

Electrospun poly-l-lactic acid (PLLA) nanofiber mats carrying surface amine groups, previously introduced by nitrogen atmospheric pressure nonequilibrium plasma, are embedded into aqueous solutions of oligomeric acrylamide-end capped AGMA1, a biocompatible polyamidoamine with arg-gly-asp (RGD)-reminiscent repeating units. The resultant mixture is finally cured giving PLLA-AGMA1 hydrogel composites that absorb large amounts of water and, in the swollen state, are translucent, soft, and pliable, yet as strong as the parent PLLA mat. They do not split apart from each other when swollen in water and remain highly flexible and resistant, since the hydrogel portion is covalently grafted onto the …

Materials Chemistry2506 Metals and AlloysPluripotent Stem CellsAgmatinePolymers and PlasticsDouble bondpolyamidoaminesPolyestersCell Culture TechniquesNanofibersBioengineering02 engineering and technology010402 general chemistry01 natural sciencesBiomaterialsPolyamidoaminePolyaminesMaterials ChemistryHydrogel compositehuman pluripotent stem cellHumansatmospheric pressure nonequilibrium plasmaInduced pluripotent stem cellatmospheric pressure nonequilibrium plasma; electrospun poly-l-lactic nanofibers; human pluripotent stem cells; poly-l-lactic acid-AGMA1 hydrogel composites; polyamidoamines; biotechnology; bioengineering; biomaterials; polymers and plastics; materials chemistry2506 metals and aloyschemistry.chemical_classificationAddition reactionPolymers and PlasticAqueous solutionTissue ScaffoldsHydrogels021001 nanoscience & nanotechnologyBiomaterial0104 chemical sciencesChemical engineeringchemistryCovalent bondNanofiberelectrospun poly-l-lactic nanofiberpoly-l-lactic acid-AGMA1 hydrogel compositeAmine gas treating0210 nano-technologyBiotechnology
researchProduct

Influence of different parameters on drug release from hydrogel systems to a biomembrane model. Evaluation by differential scanning calorimetry techn…

2000

A comparative study on the drug release capacity of four water swellable polymeric systems was carried out by differential scanning calorimetry (DSC). The polymeric systems chosen were alpha,beta-polyaspartahydrazide (PAHy) crosslinked by glutaraldehyde (GLU) (PAHy-GLU) or by ethyleneglycoldiglycidylether (EGDGE), (PAHy-EGDGE), polyvinylalcohol (PVA) crosslinked by glutaraldehyde (PVA-GLU) and alpha,beta-poly(N-hydroxyethyl)-DL-aspartamide (PHEA) by gamma irradiation (PHEA-gamma matrices). The degree of crosslinking for PAHy-GLU, PAHy-EGDGE and PVA-GLU samples was about 0.4 and 0.8. These hydrogels were characterized as free of drugs and were loaded with diflunisal (DFN) (approximately 2.5%…

Materials science12-DipalmitoylphosphatidylcholinePolymersBiophysicsDiflunisalBioengineeringBiocompatible Materialsmacromolecular substancesBiomaterialschemistry.chemical_compoundDifferential scanning calorimetryDrug Delivery SystemsPolymer chemistryMaterials TestingmedicinePolyhydroxyethyl MethacrylateLiposomeCalorimetry Differential ScanningEpoxy ResinsVesicletechnology industry and agricultureHydrogelsMembranes ArtificialDiflunisalControlled releaseNylonsCross-Linking ReagentsHydrazineschemistryChemical engineeringMechanics of MaterialsGlutaralDipalmitoylphosphatidylcholineDelayed-Action PreparationsPolyvinyl AlcoholSelf-healing hydrogelsLiposomesCeramics and CompositesGlutaraldehydemedicine.drug
researchProduct